GTC Biotherapeutics, Inc. has negative working capital of
US$13.1 million as of April 4, 2010. The Company had negative
working capital of US$16.1 million as of January 3, 2010.
provides timely updates on public companies reporting a working capital deficit to the U.S. Securities and Exchange Commission. Companies with minimum total assets of USD $5 million are covered. Liquidity Alert highlights significant events affecting liquidity, cash flows, estimated capital expenditures, and capital raising efforts.